Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,471 | -13,610 | -116,738 | 362,500 | 272,200 |
| Depreciation Amortization | 1,261 | 735 | 650 | 121,000 | 90,000 |
| Income taxes - deferred | N/A | N/A | N/A | 47,200 | -1,500 |
| Accounts receivable | N/A | N/A | N/A | 11,600 | -12,400 |
| Accounts payable and accrued liabilities | 1,540 | -1,517 | N/A | -15,400 | -50,800 |
| Other Working Capital | -10,056 | -13,964 | 26,149 | -210,400 | -302,200 |
| Other Operating Activity | 1,515 | 2,499 | 69,641 | 107,300 | 118,800 |
| Operating Cash Flow | $-37,211 | $-25,857 | $-20,298 | $423,800 | $114,100 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,939 | -2,354 | -13,124 | -40,800 | -16,300 |
| Net Acquisitions | N/A | N/A | 0 | -3,000 | N/A |
| Purchase Of Investment | -88,493 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 0 | N/A | N/A | 1,500 | 1,500 |
| Other Investing Activity | 0 | 0 | -300 | 0 | 0 |
| Investing Cash Flow | $-97,432 | $-2,354 | $-13,424 | $-42,300 | $-14,800 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 4,100 | 2,900 |
| Debt Issued | N/A | N/A | N/A | 496,000 | 495,900 |
| Debt Repayment | N/A | N/A | N/A | -1,012,700 | -832,300 |
| Common Stock Issued | 55 | 7 | N/A | 176,900 | 143,900 |
| Dividend Paid | N/A | N/A | 0 | -145,700 | -108,900 |
| Other Financing Activity | 37,833 | 37,901 | 179,727 | 12,600 | 10,900 |
| Financing Cash Flow | $37,888 | $37,908 | $179,727 | $-468,800 | $-287,600 |
| Exchange Rate Effect | N/A | N/A | 0 | -1,200 | -6,200 |
| Beginning Cash Position | 147,936 | 147,936 | 1,931 | 365,700 | 365,700 |
| End Cash Position | 51,181 | 157,633 | 147,936 | 277,200 | 171,200 |
| Net Cash Flow | $-96,755 | $9,697 | $146,005 | $-88,500 | $-194,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,211 | -25,857 | -20,298 | 423,800 | 114,100 |
| Capital Expenditure | -8,939 | -2,354 | N/A | -128,500 | -92,300 |
| Free Cash Flow | -46,150 | -28,211 | -20,298 | 295,300 | 21,800 |